ロード中...
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis
PURPOSE: Recent preclinical studies suggest combining the HSP90 inhibitor AT13387 (Onalespib) with radiation (IR) against colon cancer and head and neck squamous cell carcinoma (HNSCC). These studies emphasized that AT13387 downregulates HSP90 client proteins involved in oncogenic signaling and DNA...
保存先:
| 出版年: | Int J Radiat Oncol Biol Phys |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286306/ https://ncbi.nlm.nih.gov/pubmed/33838214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2021.03.048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|